A5001725175- Global Cancer Incidence and Screening
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Multiple and Secondary Primary Cancers
- Colorectal Cancer Screening and Detection
- Cervical Cancer and HPV Research
Cancer represents a significant source of disease burden in the United States (US), both clinically and economically. Diagnosis treatment cancer at earlier stages may reduce this burden. To better understand potential impacts diagnosis, healthcare costs among patients with were assessed by type stage diagnosis.A retrospective analysis was conducted using Optum's de-identified Integrated Claims-Clinical data set Enriched Oncology, which includes from Medicare Advantage commercially insured...
Aims Out-of-pocket (OOP) costs may constitute a substantial financial burden to patients diagnosed with cancer. Earlier stage diagnosis and treatment of cancers promote decreased morbidity mortality, subsequently also lowering costs. To better understand experienced by cancer, OOP post-diagnosis were estimated.